A New Mobile App Expands Russia’s Digital Clinical Research Platform

Automating the Routine

The mobile app for ENROLLMI, Russia’s cloud-based platform for clinical and observational research management, is already being used in two new studies: KONTAKT and VIVO. ENROLLMI is healthcare software designed for physicians and research sponsors. Because it runs on cloud servers, clients do not need to install or maintain local software.

Developed by Enrollmi.ru, a Skolkovo project participant, the platform enables full or partial reimbursement of patient expenses for prescribed medications or laboratory tests and can issue referrals for prepaid consultations or diagnostics.

Only patients enrolled in studies conducted through the platform can participate in these support programs. The mobile application simplifies and accelerates many operational processes for both participants and study organizers. Through the app, patients can electronically sign informed consent forms for personal data processing and complete questionnaires according to scheduled visits.

When consent is signed via the mobile interface, study documentation becomes tamper-resistant, preventing retroactive changes. Patients retain ongoing access to their examination records and can manage their participation decisions in compliance with legal requirements.

Lab Choice Without Constraints

In traditional observational programs, logistical and legal complexities often arise around material support for research centers. ENROLLMI’s reimbursement mechanism addresses this issue. Organizers no longer need to manage drug supply chains or direct participants to specific laboratories.

We chose not to spend time trying to circumvent unlawful restrictions imposed by Google on Russian developers and instead immediately placed our Android application on RuStore. With Apple, however, we had to engage in an extended legal discussion regarding how US legislation applies to iOS applications operating in Russia. But reasonable people can be found everywhere. After a month of professional discussions, we received approval to publish our application in the App Store

Mikhail Getman

Founder and CEO of Enrollmi.ru, Professor at the Higher School of Economics (Moscow)

Patients can receive reimbursement of up to 100 percent of medication costs or laboratory fees, regardless of price, pharmacy or testing center. The platform reports more than 7,500 physicians connected to ENROLLMI, and over five years it has completed more than 50 studies across 15 medical specialties.

The launch of the mobile application illustrates how digital healthcare services can align with national data and electronic signature regulations. It also reflects a broader effort by Russian companies and institutions to reduce dependence on foreign digital ecosystems.

Strengthening Digital Healthcare Infrastructure

For Russia’s healthcare system, developing IT products like ENROLLMI is strategically important. The platform facilitates direct interaction between medical service providers and patients without bureaucratic friction, improves data quality and increases participant engagement in clinical research. Over time, the mobile app’s functionality could expand to include integration with government digital services and automated patient support features.

Currently, the application supports the KONTAKT and VIVO programs, which focus on studying an innovative Russian medication used in course-based therapy for osteoarthritis of atypical localization and in research on chronic venous disease treatment. In the future, the ENROLLMI team plans to deploy the app in additional large-scale studies, potentially accelerating adoption of digital tools in routine clinical practice.